BRIEF-U.S.-listed shares of Acasti Pharma up 10.7 percent premarket
January 09, 2014 at 08:05 AM EST
NEW YORK, Jan 9 (Reuters) - Acasti Pharma Inc : * U.S.-listed shares of Acasti Pharma up 10.7 percent to $1.55 in premarket after the FDA clears its investigational new drug submission to conduct a pharmacokinetic trial
